<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01626911</url>
  </required_header>
  <id_info>
    <org_study_id>CRAI-H</org_study_id>
    <nct_id>NCT01626911</nct_id>
  </id_info>
  <brief_title>Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis</brief_title>
  <acronym>CRAI-H</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our animal studies found that continuous regional arterial infusion (CRAI in the celiac
      trunk) of low molecular weight heparin (LMWH) could alleviate inflammation, improve global
      hemodynamics and restore organ function in a porcine model of severe acute pancreatitis
      (SAP,unpublished).

      In this study, the investigators aim to evaluate the effects of CRAI of LMWH in the treatment
      of SAP patients. The investigators suppose CRAI could help improve the outcomes of these
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>coagulation related complications</measure>
    <time_frame>14 days after the placement of celiac trunk catheter</time_frame>
    <description>bleeding for the most
coagulative parameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pancreatic infection</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pancreatic necrosis</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU duration</measure>
    <time_frame>Participants will be followed until the date of discharge from the ICU,assessed up to 6 weeks. Patients who die during hospitalization are excluded from this measurement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital duration</measure>
    <time_frame>Participants will be followed until the date of discharge from the hospital,assessed up to 3 months. Patients who die during hospitalization are excluded from this measurement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Participants will be followed until the date of discharge or the date of death from any cause, whichever came first, assessed up to 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>CRAI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRAI of LMWH in the celiac trunk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conservative treatment without CRAI, control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous regional arterial infusion of low molecular weight heparin in celiac trunk</intervention_name>
    <description>Put a catheter to the celiac trunk through interventional technique. The approach to celiac trunk was via a femoral artery approach.The tip of the arterial catheter (4F) was placed in celiac trunk which could perfuse the pancreas.After that, continuous infusion of low molecular weight heparin through the catheter will be applied during the first 5 days after placement.</description>
    <arm_group_label>CRAI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>General treatment</intervention_name>
    <description>Include fluid resuscitation, percutaneous drainage if needed, antibiotics,organ support, etc.</description>
    <arm_group_label>CRAI</arm_group_label>
    <arm_group_label>Conservative treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptoms and signs of severe acute pancreatitis according to Atlanta criteria

          -  Within 3 days from the onset of the disease

          -  Available for interventional treatment(not sensible to radiocontrast agent)

        Exclusion Criteria:

          -  Pregnant pancreatitis

          -  Receiving surgery or aspiration before;need of early surgery

          -  Patients with coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weiqin Li, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jinling Hospital, School of Medicine, Nanjing University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Weiqin Li, Dr</last_name>
    <phone>+86-025-80860066</phone>
    <email>kkb9832@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhihui Tong, Dr</last_name>
    <phone>+86-025-80860066</phone>
    <email>njzyantol@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiqin Li, Dr</last_name>
      <phone>+86-025-80860066</phone>
      <email>kkb9832@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lu Ke, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luyao Zhang, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Lu XS, Qiu F, Li YX, Li JQ, Fan QQ, Zhou RG. Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis. Pancreas. 2010 May;39(4):516-9. doi: 10.1097/MPA.0b013e3181c3c954.</citation>
    <PMID>20104197</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2012</study_first_submitted>
  <study_first_submitted_qc>June 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2012</study_first_posted>
  <last_update_submitted>December 6, 2013</last_update_submitted>
  <last_update_submitted_qc>December 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing University School of Medicine</investigator_affiliation>
    <investigator_full_name>Weiqin Li</investigator_full_name>
    <investigator_title>Director of surgical ICU</investigator_title>
  </responsible_party>
  <keyword>severe acute pancreatitis;</keyword>
  <keyword>continuous regional arterial infusion;</keyword>
  <keyword>low molecular weight heparin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

